Actively Recruiting
Latarjet Versus Modified Eden-Hybinette for Anterior Shoulder Dislocation
Led by University of Sao Paulo · Updated on 2026-01-29
60
Participants Needed
1
Research Sites
691 weeks
Total Duration
On this page
Sponsors
U
University of Sao Paulo
Lead Sponsor
F
Faculdade de Medicina de Jundiaí
Collaborating Sponsor
AI-Summary
What this Trial Is About
Randomized clinical trial, parallel 1:1, comparing Latarjet to Modified Eden-Hybinette (iliac bone crest + capsular repair) for recurrent traumatic anterior glenohumeral dislocation.
CONDITIONS
Official Title
Latarjet Versus Modified Eden-Hybinette for Anterior Shoulder Dislocation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- History of one or more previous episodes of traumatic glenohumeral dislocation
- Anterior glenoid bone loss greater than 20% of its diameter
- Recurrence of glenohumeral dislocation after arthroscopic Bankart repair
- Instability Severity Index Score (ISIS) of 4 or higher with anterior glenoid bone loss greater than 13.5%
- Presence of Hill-Sachs lesion and glenoid considered "off-track"
You will not qualify if you...
- Hill-Sachs lesion larger than 40% of the humeral head diameter
- Untreated seizures
- Complete rotator cuff tear previously diagnosed
- Fractures of the proximal humerus (except Hill-Sachs lesions)
- Multidirectional shoulder instability
- Advanced glenohumeral osteoarthritis (grade 3 Samilson and Pietro)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Instituto de Ortopedia e Traumatologia
São Paulo, São Paulo, Brazil, 05403-010
Actively Recruiting
Research Team
M
Mauro EC Gracitelli, PhD
CONTACT
E
Eduardo A Malavolta, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here